Acasti Pharma Inc. (ACST)

Acasti Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Net Income	-12.85	-42.43	-9.82	-19.68	-25.51
Depreciation & Amortization	0.01	0.12	0	0.92	2.32
Share-Based Compensation	0.91	1.81	1.34	1.17	1.95
Other Operating Activities	-0.4	24.58	-8.75	3.26	-1.71
Operating Cash Flow	-12.33	-15.91	-17.23	-14.32	-22.95
Capital Expenditures	0.09	-0.02	0	-0.07	-0.32
Change in Investments	0.02	13.17	-3.52	-9.79	8.46
Investing Cash Flow	0.1	13.15	-3.52	-9.86	8.14
Share Issuance / Repurchase	7.36	0.3	0	59.63	14.73
Debt Issued / Paid	0	0	0	0	-1.56
Other Financing Activities	-	-	-	-0.14	0.01
Financing Cash Flow	7.36	0.3	0	59.49	13.18
Exchange Rate Effect	0	-0.01	0.15	1.39	-1
Net Cash Flow	-4.87	-2.46	-20.6	36.7	-2.63
Free Cash Flow	-12.24	-15.93	-17.23	-14.39	-23.27
Free Cash Flow Margin	-	-	-	-7340.82%	-
Free Cash Flow Per Share	-1.28	-2.14	-2.81	-5.82	-13.21

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).